Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_assertion description "[We also found that Ik6 variant and CRLF2 overexpression had an important role in dictating the prognosis of Ph-negative patients, which may be useful markers in guiding the treatment of ALL in the future, with tyrosine kinase inhibitors on the other hand reversing the fate of Ph-positive ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_assertion evidence source_evidence_literature NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_assertion SIO_000772 22297722 NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_assertion wasDerivedFrom befree-20140225 NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_assertion wasGeneratedBy ECO_0000203 NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP340254.RAC7ex_rYh0eL2FUxmjgJDjq6U-HwmARscsgXN1yGN7d8130_provenance.